BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 27
• 28
• 29
• 30
• 31

• Business

  Wave Life Sciences First Quarter 2024 Financial Results Scheduled for May 9, 2024

  Wave Life Sciences Ltd. will host a live webcast and conference call at 8:30 a.m. ET on Thursday, May 9, 2024, to review the company’s first quarter 2024 financial results and provide business updates.

  May 2, 2024

   · 

  1 min read
• Biotech Beach

  Palisade Bio Announces $4 Million Private Placement Priced At-The- Market Under Nasdaq Rules

  Palisade Bio, Inc. is announcing that it has entered into a definitive agreement with an institutional investor for the purchase of 615,242 shares of common stock in a private placement at a purchase price per share of $6.5015, priced at-the-market under Nasdaq rules.

  May 2, 2024

   · 

  5 min read
• Business

  Petauri™ Further Expands with Accomplished Evidence and Strategy Executives

  Petauri announced the addition of Nicole Lodowski and Bob Nordyke to lead a team dedicated to evidence generation and value strategy across the product lifecycle, from early pipeline evidence planning through post-launch evidence generation.

  May 2, 2024

   · 

  4 min read
• Drug Development

  MedStar Health Launches Participation in Phase 3 MAGNITUDE Gene-Editing Study with First U.S. Heart Patient Treated at MedStar Washington Hospital Center

  The first U.S. heart patient involved in a study for a new gene-editing therapy directly infused inside the body has successfully been enrolled at MedStar Washington Hospital Center.

  May 2, 2024

   · 

  2 min read
• Business

  Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on May 13, 2024

  Lucid Diagnostics Inc. today announced that it will host a business update conference call and webcast on Monday, May 13, 2024, at 8:30 AM ET.

  May 2, 2024

   · 

  2 min read
• Business

  SFA Therapeutics Strengthens Management Team with Appointment of Chief Medical Officer

  SFA Therapeutics, Inc. today announced the appointment of Stefan C. Weiss , MD, MBA, as Chief Medical Officer.

  May 2, 2024

   · 

  3 min read
• Biotech Bay

  Mekonos Enters Partnership Agreement with Accelerated Biosciences to Develop and Commercialize Engineered Human Trophoblast Stem Cells (hTSCs) for Biomanufacturing

  Mekonos, Inc. announced it has entered into a partnership agreement with Accelerated Biosciences Corp. to codevelop a powerful, new manufacturing cell line based on Accelerated Bio’s human Trophoblast Stem Cells and Gene Engineered Multi-Sites technology.

  May 2, 2024

   · 

  4 min read
• Business

  Amylyx Pharmaceuticals to Report First Quarter 2024 Financial Results on May 9, 2024

  Amylyx Pharmaceuticals, Inc. (Nasdaq: AMLX) (“Amylyx” or the “Company”) will report its first quarter 2024 financial results on Thursday, May 9, 2024.

  May 2, 2024

   · 

  1 min read
• Business

  NeuroSense Announces First Quarter 2024 Business Update

  NeuroSense Therapeutics Ltd. (Nasdaq: NRSN) (“NeuroSense”), a company developing novel treatments for severe neurodegenerative diseases, today provides a business update.

  May 2, 2024

   · 

  6 min read
• Business

  Accelerate Diagnostics Scheduled Call to Review 2024 First Quarter Results.

  Accelerate Diagnostics, Inc. (NASDAQ: AXDX) announced today that management will host a conference call on Wednesday, May 8, 2024, at 4:30 p.m. Eastern Time to review 2024 first quarter results.

  May 2, 2024

   · 

  1 min read